A case report of a multivessel coronary vasospasm that responded to IV diazepam

Fares Abboud1, Mustafa Zain2, Ahmad Alsaadi2

  • 1Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic.

Medicine
|September 17, 2025
PubMed

Insights

Intravenous diazepam effectively treated multivessel coronary artery vasospasm (CAVS) unresponsive to standard treatments, particularly when linked to psychological stress. This case highlights a potential new therapy for refractory CAVS.

Area of Science:

  • Cardiology
  • Pharmacology
  • Psychosomatic Medicine

Background:

  • Coronary artery vasospasm (CAVS) can mimic coronary artery disease, leading to unnecessary interventions.
  • Psychological stress is increasingly recognized as a factor in cardiovascular events.

Purpose of the Study:

  • To report the efficacy of intravenous (IV) diazepam in managing multivessel CAVS.
  • To explore the role of psychological stress in CAVS refractory to standard vasodilators.

Main Methods:

  • A case report of a 32-year-old male with multivessel CAVS unresponsive to intracoronary nitroglycerin and verapamil.
  • Administration of 5 mg IV diazepam during a panic attack.
  • Repeat coronary angiography to assess treatment response.

Main Results:

  • IV diazepam administration led to complete symptom resolution.
  • Repeat angiography showed normal coronary arteries, with no evidence of plaques or stenosis.
  • The patient's response occurred during a panic attack, suggesting a link to psychological stress.

Conclusions:

  • Multivessel CAVS refractory to standard vasodilators can be effectively treated with IV diazepam.
  • Psychological stress may play a significant role in CAVS, and benzodiazepines could be a therapeutic option.
  • Further research is needed to confirm the efficacy of IV diazepam and explore the stress-CAVS connection.
Abstract

Related Concept Videos

Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.3K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
675
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
3.3K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.6K